ENOBIA PHARMA CORP

Profile

Company Names

ENOBIA PHARMA CORP

Addresses

2901 RACHEL ST., SUITE 23, MONTREAL, A8 H1W 4A4

C/O ENOBIA PHARMA INC., 2901 RACHEL ST., SUITE 23, MONTREAL, A8 H1W 4A4

C/O ENOBIA PHARMA CORP., 2901 RACHEL ST., SUITE 23, MONTREAL, A8 H1W 4A4

2901 RACHEL STR, SUITE 23, MONTREAL, A8 H1W 4A4

Phone Numbers

514-596-2901

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2007

State Incorporated:

DELAWARE

Total Amount Raised:

$85,000,000.00

Number of Funding Rounds:

3
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
3
2011-08-09 
$20,000,000.00 
$40,000,000.00 
$20,000,000.00 
Equity 
2
2011-03-21 
$15,000,000.00 
$46,969,070.00 
$31,969,070.00 
Equity 
1
2009-08-05 
$50,000,000.00 
$50,000,000.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
DAVID 
 
BONITA 
DIRECTOR
VIEWRAY INC   |  ENOBIA PHARMA CORP   |  LOXO ONCOLOGY, INC.   |  TRICIDA, INC.   |  VIEWRAY, INC.   |  ACUTUS MEDICAL, INC.   |  SI-BONE, INC.   |  PRELUDE THERAPEUTICS INC.   |  PRELUDE THERAPEUTICS INC   |  IMARA INC.   |  ORBIMED PARTNERS II, L.P.   |  ORBIMED GLOBAL HEALTHCARE ASSOCIATES FUND, L.P.   |  ORBIMED GLOBAL HEALTHCARE FUND, L.P.   |  TREELINE BIOSCIENCES, INC.   |  IKENA ONCOLOGY, INC.   |  ADELA, INC.   |  THROMBOLEX, INC.
LUC 
 
COURNOYER 
EXECUTIVE OFFICER
ENOBIA PHARMA CORP
ROBERT 
 
HEFT 
DIRECTOR, EXECUTIVE OFFICER
ENOBIA PHARMA CORP   |  LUMOS PHARMA, INC.   |  CLEMENTIA PHARMACEUTICALS INC.
JEFFREY 
 
MACK 
EXECUTIVE OFFICER
ENOBIA PHARMA CORP   |  CACHET FINANCIAL SOLUTIONS, INC.   |  DIGILITI MONEY GROUP, INC.   |  NORTHERN RELIABILITY, INC.   |  CROATAN MIDTOWN RECAP LLC
LUC 
 
MAINVILLE 
DIRECTOR
ENOBIA PHARMA CORP   |  ORTHO REGENERATIVE TECHNOLOGIES INC.   |  VALEO PHARMA INC.
RICHARD 
 
MEADOWS 
DIRECTOR
ENOBIA PHARMA CORP   |  PRIVATE SOLUTION DETOX CORP.
FREDERIC 
 
PRICE 
DIRECTOR
ENOBIA PHARMA CORP
THOMAS 
 
SCHUETZ 
DIRECTOR
ENOBIA PHARMA CORP   |  RELYPSA INC   |  ARTEAUS THERAPEUTICS, LLC   |  AUDENTES THERAPEUTICS, INC.   |  COMPASS THERAPEUTICS LLC
JONATHAN 
 
SILVERSTEIN 
DIRECTOR
CERAPEDICS INC   |  ENOBIA PHARMA CORP   |  DFINE INC   |  RELYPSA INC   |  ROKA BIOSCIENCE, INC.   |  ASCENDIS PHARMA A/S   |  AUDENTES THERAPEUTICS, INC.   |  ADICET BIO, INC.   |  RHYTHM PHARMACEUTICALS, INC.   |  SCPHARMACEUTICALS INC.   |  AVEDRO INC   |  NEUROPACE INC   |  SPRINGBOX LABS, INC.   |  ARCUTIS BIOTHERAPEUTICS, INC.   |  SURMOUNT BIO, INC.   |  VANQUA BIO, INC.
ERIC 
L. 
TRACHTENBERG 
EXECUTIVE OFFICER
ENOBIA PHARMA CORP   |  TRIBUTE PHARMACEUTICALS CANADA INC.   |  ARALEZ PHARMACEUTICALS INC.   |  KALA PHARMACEUTICALS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2011-08-24
D
Link
BIOTECHNOLOGY 
 
$1 - $1,000,000 
Equity 
2011-08-09 
2011-04-01
D
Link
BIOTECHNOLOGY 
 
$1 - $1,000,000 
Equity 
2011-03-21 
2010-12-13
D/A
Link
BIOTECHNOLOGY 
 
$1 - $1,000,000 
Equity 
2009-08-05 
2009-08-28
D
Link
BIOTECHNOLOGY 
 
$1 - $1,000,000 
Equity 
2009-08-05 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#